These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 26524087)

  • 1. Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.
    Laviana AA; Ilg AM; Veruttipong D; Tan HJ; Burke MA; Niedzwiecki DR; Kupelian PA; King CR; Steinberg ML; Kundavaram CR; Kamrava M; Kaplan AL; Moriarity AK; Hsu W; Margolis DJ; Hu JC; Saigal CS
    Cancer; 2016 Feb; 122(3):447-55. PubMed ID: 26524087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-driven activity-based cost comparison of prostate cancer brachytherapy and intensity-modulated radiation therapy.
    Dutta SW; Bauer-Nilsen K; Sanders JC; Trifiletti DM; Libby B; Lash DH; Lain M; Christodoulou D; Hodge C; Showalter TN
    Brachytherapy; 2018; 17(3):556-563. PubMed ID: 29519605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-driven activity-based costing of low-dose-rate and high-dose-rate brachytherapy for low-risk prostate cancer.
    Ilg AM; Laviana AA; Kamrava M; Veruttipong D; Steinberg M; Park SJ; Burke MA; Niedzwiecki D; Kupelian PA; Saigal C
    Brachytherapy; 2016; 15(6):760-767. PubMed ID: 27720202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active surveillance vs. treatment for low-risk prostate cancer: a cost comparison.
    Eldefrawy A; Katkoori D; Abramowitz M; Soloway MS; Manoharan M
    Urol Oncol; 2013 Jul; 31(5):576-80. PubMed ID: 21616691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing.
    Ning MS; Klopp AH; Jhingran A; Lin LL; Eifel PJ; Vedam S; Lawyer AA; Olivieri ND; Guzman AB; Incalcaterra JR; Mesko SM; Pezzi TA; Boyce-Fappiano DR; Shaitelman SF; Frank SJ; Thaker NG
    Brachytherapy; 2019; 18(4):445-452. PubMed ID: 30992185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low/intermediate prostate cancer.
    Shah C; Lanni TB; Ghilezan MI; Gustafson GS; Marvin KS; Ye H; Vicini FA; Martinez AA
    Brachytherapy; 2012; 11(6):441-5. PubMed ID: 22728157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modulated Radiotherapy, and Proton Beam Therapy.
    Schroeck FR; Jacobs BL; Bhayani SB; Nguyen PL; Penson D; Hu J
    Eur Urol; 2017 Nov; 72(5):712-735. PubMed ID: 28366513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost implications of the rapid adoption of newer technologies for treating prostate cancer.
    Nguyen PL; Gu X; Lipsitz SR; Choueiri TK; Choi WW; Lei Y; Hoffman KE; Hu JC
    J Clin Oncol; 2011 Apr; 29(12):1517-24. PubMed ID: 21402604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of treatments for patients with localized prostate cancer in Europe: a systematic review.
    Becerra V; Ávila M; Jimenez J; Cortes-Sanabria L; Pardo Y; Garin O; Pont A; Alonso J; Cots F; Ferrer M;
    BMC Health Serv Res; 2016 Oct; 16(1):541. PubMed ID: 27716267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multidimensional Analysis of Prostate Surgery Costs in the United States: Robotic-Assisted versus Retropubic Radical Prostatectomy.
    Bijlani A; Hebert AE; Davitian M; May H; Speers M; Leung R; Mohamed NE; Sacks HS; Tewari A
    Value Health; 2016 Jun; 19(4):391-403. PubMed ID: 27325331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis.
    Hayes JH; Ollendorf DA; Pearson SD; Barry MJ; Kantoff PW; Lee PA; McMahon PM
    Ann Intern Med; 2013 Jun; 158(12):853-60. PubMed ID: 23778902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An economic analysis of conservative management versus active treatment for men with localized prostate cancer.
    Perlroth DJ; Bhattacharya J; Goldman DP; Garber AM
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):250-7. PubMed ID: 23271781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximizing resources in the local treatment of prostate cancer: A summary of cost-effectiveness studies.
    Muralidhar V; Nguyen PL
    Urol Oncol; 2017 Feb; 35(2):76-85. PubMed ID: 27473636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Economic Analysis of Open and Robot-assisted Laparoscopic Surgery for Prostate Cancer Within the Prospective Multicentre LAPPRO Trial.
    Forsmark A; Gehrman J; Angenete E; Bjartell A; Björholt I; Carlsson S; Hugosson J; Marlow T; Stinesen-Kollberg K; Stranne J; Wallerstedt A; Wiklund P; Wilderäng U; Haglind E
    Eur Urol; 2018 Dec; 74(6):816-824. PubMed ID: 30143383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer.
    Shaverdian N; Verruttipong D; Wang PC; Kishan AU; Demanes DJ; McCloskey S; Kupelian P; Steinberg ML; King CR
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):516-525. PubMed ID: 28126301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of SBRT versus IMRT for low-risk prostate cancer.
    Sher DJ; Parikh RB; Mays-Jackson S; Punglia RS
    Am J Clin Oncol; 2014 Jun; 37(3):215-21. PubMed ID: 23275277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic analysis of active surveillance for localized prostate cancer.
    Kim S; Dall'Era MA; Evans CP
    Curr Opin Urol; 2012 May; 22(3):247-53. PubMed ID: 22388666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer.
    Bolenz C; Gupta A; Hotze T; Ho R; Cadeddu JA; Roehrborn CG; Lotan Y
    Eur Urol; 2010 Mar; 57(3):453-8. PubMed ID: 19931979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer.
    Halpern JA; Sedrakyan A; Hsu WC; Mao J; Daskivich TJ; Nguyen PL; Golden EB; Kang J; Hu JC
    Cancer; 2016 Aug; 122(16):2496-504. PubMed ID: 27224858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.